Patients in the neurologic cohort were more likely to die post-discharge compared to controls.
COVID-19 patients with neurologic symptoms have worse outcomes for up to 3 years, data show
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Very few US adults getting new flu, COVID, RSV vaccines, even in nursing homes
- US respiratory virus activity remains low ahead of holiday season
- Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients
- Adults with migraines at higher risk of depression during pandemic, study shows